Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems

Finger, Robert; Daien, Vincent; Eldem, Bora; Talks, James; Korobelnik, Jean-Francois; Mitchell, Paul; Sakamoto, Taiji; Wong, Tien; Pantiri, Krystallia; Carrasco, Joao

doi:10.1186/s12886-020-01554-2

Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems

Atıf İçin Kopyala

Finger R. P., Daien V., Eldem B. M., Talks J. S., Korobelnik J., Mitchell P., ...Daha Fazla

BMC OPHTHALMOLOGY, cilt.20, sa.1, 2020 (SCI-Expanded)

Yayın Türü: Makale / Derleme
Cilt numarası: 20 Sayı: 1
Basım Tarihi: 2020
Doi Numarası: 10.1186/s12886-020-01554-2
Dergi Adı: BMC OPHTHALMOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Systematically review the evidence describing the impact of anti-vascular endothelial growth factor (anti-VEGF) therapy on neovascular age-related macular degeneration (nAMD) patient outcomes and healthcare resource utilization.